We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
FDA批准首个慢性丁型肝炎药物——bulevirtide。机制、剂量、风险、价格及预后。了解适合治疗的人群。
